BNTX
Closed
Biontech Se
107.51
+1.04 (+0.98%)
Last Update: 01 Jul 2025 23:09:00
Yesterday: 106.47
Day's Range: 105.345 - 109.68
Send
sign up or login to leave a comment!
When Written:
124.57
BioNTech SE is a German biotechnology company that specializes in developing personalized cancer immunotherapies and vaccines for infectious diseases. The company was founded in 2008 by Dr. Ugur Sahin and Dr. Özlem Türeci in Mainz, Germany. BioNTech's main focus is on developing mRNA-based therapies, which use genetic material to instruct cells to produce proteins that trigger an immune response against specific diseases.
BioNTech gained international recognition in 2020 for its collaboration with Pfizer to develop the first COVID-19 vaccine to receive emergency use authorization from regulatory agencies. The vaccine, known as BNT162b2 or the Pfizer-BioNTech COVID-19 vaccine, has been shown to be highly effective in preventing COVID-19 and has been administered to millions of people worldwide.
BioNTech also has several other clinical-stage programs in development, including cancer immunotherapies that target solid tumors and rare diseases. The company has partnerships with several pharmaceutical companies, including Roche, Sanofi, and Genmab, and has received significant investment from venture capital firms and government organizations.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
BioNTech gained international recognition in 2020 for its collaboration with Pfizer to develop the first COVID-19 vaccine to receive emergency use authorization from regulatory agencies. The vaccine, known as BNT162b2 or the Pfizer-BioNTech COVID-19 vaccine, has been shown to be highly effective in preventing COVID-19 and has been administered to millions of people worldwide.
BioNTech also has several other clinical-stage programs in development, including cancer immunotherapies that target solid tumors and rare diseases. The company has partnerships with several pharmaceutical companies, including Roche, Sanofi, and Genmab, and has received significant investment from venture capital firms and government organizations.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!